Janney Montgomery Scott’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59M | Sell |
14,955
-255
| -2% | -$27.1K | ﹤0.01% | 1316 |
|
|
2025
Q1 | $1.89M | Buy |
+15,210
| New | +$1.89M | 0.01% | 1185 |
|
|
2024
Q4 | – | Sell |
-10,266
| Closed | -$1.14M | – | 2774 |
|
|
2024
Q3 | $1.14M | Sell |
10,266
-656
| -6% | -$73.1K | ﹤0.01% | 1425 |
|
|
2024
Q2 | $1.17M | Sell |
10,922
-4,966
| -31% | -$530K | ﹤0.01% | 1360 |
|
|
2024
Q1 | $1.91M | Buy |
15,888
+4,939
| +45% | +$595K | 0.01% | 1172 |
|
|
2023
Q4 | $1.35M | Buy |
10,949
+3,591
| +49% | +$442K | ﹤0.01% | 1287 |
|
|
2023
Q3 | $952K | Buy |
+7,358
| New | +$952K | ﹤0.01% | 1370 |
|
|
2021
Q3 | – | Sell |
-24,759
| Closed | -$4.4M | – | 2335 |
|
|
2021
Q2 | $4.4M | Buy |
+24,759
| New | +$4.4M | 0.02% | 633 |
|
|
2019
Q4 | – | Sell |
-4,562
| Closed | -$585K | – | 2108 |
|
|
2019
Q3 | $585K | Sell |
4,562
-2,622
| -36% | -$336K | ﹤0.01% | 1297 |
|
|
2019
Q2 | $1.02M | Buy |
7,184
+401
| +6% | +$57.2K | 0.01% | 1039 |
|
|
2019
Q1 | $970K | Sell |
6,783
-70
| -1% | -$10K | 0.01% | 1047 |
|
|
2018
Q4 | $849K | Buy |
6,853
+519
| +8% | +$64.3K | 0.01% | 1013 |
|
|
2018
Q3 | $1.07M | Buy |
6,334
+2,665
| +73% | +$448K | 0.01% | 995 |
|
|
2018
Q2 | $632K | Buy |
3,669
+64
| +2% | +$11K | 0.01% | 1261 |
|
|
2018
Q1 | $544K | Buy |
3,605
+1,619
| +82% | +$244K | 0.01% | 1290 |
|
|
2017
Q4 | $267K | Buy |
1,986
+226
| +13% | +$30.4K | ﹤0.01% | 1645 |
|
|
2017
Q3 | $257K | Buy |
1,760
+400
| +29% | +$58.4K | ﹤0.01% | 1583 |
|
|
2017
Q2 | $211K | Buy |
+1,360
| New | +$211K | ﹤0.01% | 1601 |
|
|
2013
Q3 | – | Sell |
-3,426
| Closed | -$235K | – | 1905 |
|
|
2013
Q2 | $235K | Buy |
+3,426
| New | +$235K | 0.02% | 620 |
|